|
|||||
|
|
The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis |
|
| Abstract: | |
| Keywords: | anakinra arthritis IL-1 receptor antagonist juvenile idiopathic arthritis Still's disease systemic |